Vicus Capital Buys 717 Shares of CVS Health Co. (NYSE:CVS)

Vicus Capital raised its stake in shares of CVS Health Co. (NYSE:CVS) by 12.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,330 shares of the pharmacy operator’s stock after purchasing an additional 717 shares during the quarter. Vicus Capital’s holdings in CVS Health were worth $505,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of the stock. SOA Wealth Advisors LLC. raised its stake in shares of CVS Health by 4.9% during the fourth quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock worth $226,000 after acquiring an additional 133 shares in the last quarter. Apella Capital LLC raised its stake in shares of CVS Health by 4.2% during the fourth quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock worth $272,000 after acquiring an additional 136 shares in the last quarter. Prairie Sky Financial Group LLC raised its stake in shares of CVS Health by 4.1% during the fourth quarter. Prairie Sky Financial Group LLC now owns 3,612 shares of the pharmacy operator’s stock worth $285,000 after acquiring an additional 141 shares in the last quarter. WealthShield Partners LLC increased its stake in shares of CVS Health by 3.2% in the fourth quarter. WealthShield Partners LLC now owns 4,498 shares of the pharmacy operator’s stock worth $355,000 after buying an additional 141 shares during the period. Finally, Sugarloaf Wealth Management LLC increased its stake in shares of CVS Health by 9.5% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 1,639 shares of the pharmacy operator’s stock worth $129,000 after buying an additional 142 shares during the period. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

CVS has been the topic of several recent analyst reports. The Goldman Sachs Group cut their price target on shares of CVS Health from $85.00 to $74.00 and set a “buy” rating on the stock in a report on Thursday, May 2nd. Argus cut their price target on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, May 8th. UBS Group cut shares of CVS Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $85.00 to $60.00 in a report on Thursday, May 2nd. SVB Leerink restated a “market perform” rating and set a $60.00 target price (down previously from $87.00) on shares of CVS Health in a report on Wednesday, May 1st. Finally, Baird R W upgraded shares of CVS Health to a “hold” rating in a report on Thursday, May 30th. Eleven investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $75.05.

Insiders Place Their Bets

In other CVS Health news, Director Edward J. Ludwig bought 1,000 shares of the firm’s stock in a transaction on Thursday, May 2nd. The stock was acquired at an average price of $53.88 per share, with a total value of $53,880.00. Following the transaction, the director now owns 21,630 shares in the company, valued at $1,165,424.40. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.24% of the stock is owned by insiders.

CVS Health Stock Performance

NYSE:CVS traded up $0.70 during mid-day trading on Friday, reaching $59.06. The company’s stock had a trading volume of 14,343,538 shares, compared to its average volume of 11,322,786. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The firm’s fifty day moving average price is $59.56 and its two-hundred day moving average price is $70.17. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. The stock has a market cap of $74.14 billion, a P/E ratio of 10.38, a PEG ratio of 0.56 and a beta of 0.53.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The business had revenue of $88.44 billion during the quarter, compared to analysts’ expectations of $89.33 billion. During the same period last year, the firm posted $2.20 EPS. CVS Health’s quarterly revenue was up 3.7% compared to the same quarter last year. On average, equities analysts forecast that CVS Health Co. will post 7.02 EPS for the current fiscal year.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.